Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CYP2C56P is a non-functional pseudogene belonging to the human cytochrome P450 superfamily, specifically to the family 2, subfamily C. It does not code for an active enzyme, and thus has no established biological or pharmacological function[7][2]. The larger CYP2C family encodes enzymes that metabolize drugs and endogenous compounds, but pseudogenes like CYP2C56P have accumulated mutations or structural alterations rendering them incapable of producing functional proteins[2][7]. While some pseudogenes may regulate other genes via RNA-based mechanisms, there is no specific evidence that CYP2C56P plays such a role[7][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 family 2 subfamily C member 56, pseudogene (CYP2C56P).